Immunization

In a move that comes as a surprise to Moderna and various vaccine experts, the FDA continues its skeptic exploration of mRNA vaccine technology.

CDC updates vaccination guidelines, emphasizing individual choice for COVID-19 and standalone chickenpox shots, while addressing vaccine hesitancy and misinformation.

Pharmacists enhance travel medicine by offering tailored consultations, risk assessments, and vaccine management, ensuring safe international travel for patients.

The American Academy of Pediatrics responds to recent HHS vaccine guideline changes with its own schedule for childhood and adolescent patients.

Consultant pharmacists enhance vaccination efforts in long-term care, addressing challenges like vaccine fatigue while advocating for age-friendly care and improved patient outcomes.

As respiratory virus season approaches, misinformation threatens lives; understanding vaccines is crucial for protecting our communities and future.

Consultant pharmacists enhance long-term care by integrating vaccination strategies, educating staff, and addressing the unique needs of older adults.

Medical organizations challenge the government's revised childhood vaccine schedule, urging Congress for immediate oversight and action to protect public health.

Addressing the lack of evidence regarding pharmacists’ roles as immunization authorities on infant respiratory syncytial virus (RSV) vaccines.

US adults were surveyed about their understanding of shared clinical decision-making following the HHS overhaul of childhood vaccines.

COVID-19 vaccination significantly reduces long-term mortality risk in chronic obstructive pulmonary disease patients, highlighting its importance for respiratory health and safety.

Although several vaccines are still being recommended, a variety of those protecting against respiratory viruses and other diseases have been narrowed on child vaccine schedules.

Spanning those focused on pneumococcal diseases to continued developments of vaccines against COVID-19, these are the most-read immunization stories from 2025.

A recent study reveals COVID-19 vaccination significantly reduces severe maternal disease and preterm birth risks during pregnancy.

With little evidence on vaccine coverage for people living with HIV, researchers explored pneumococcal vaccine rates between 2014 and 2023.

An expert discusses how pharmacists are transforming from passive dispensers to active public health care members by proactively identifying and recommending vaccines to patients.

Pharmacists show compassion and support for their communities and patients, highlighting impactful vaccination efforts and dedication to patient care.

With constant vaccine and guideline updates reserved for pneumococcal diseases, pharmacists continue to be the authority on pneumococcal vaccine administration.

In part 3 of our interview with Megan Smith, PharmD, she discusses the common reasons for hesitancy among patients, specifically for the pneumococcal vaccine.

An expert discusses how pharmacists must balance patient demand with high logistical costs and risks when stocking specialized travel vaccines (eg, yellow fever) due to high acquisition cost.

Megan Smith, PharmD, discusses how pharmacists have taken reigns in boosting pneumococcal vaccine rates across health care.

Megan Smith, PharmD, breaks down the public health sector’s current understanding and approach toward pneumococcal vaccines.

Exploring the real-time capabilities of chatbots and artificial intelligence (AI), researchers investigate how this technology would impact older adults’ pneumococcal vaccine rates.

This announcement is another move stemming from the federal government's skeptic views on vaccine technology and its efficacy among US patients.

Vaccine hesitancy rises as new recommendations emerge, highlighting pharmacists’ crucial role in addressing misinformation and improving immunization rates.